Superworth

Traws Pharma price to sales ratio TRAW

Market value divided by revenue over the last twelve months, since 2014.

Today, Oct 23, 2026
n/m
not a meaningful number
Last meaningful
3.1×
Aug 2026
10-year median
25.8×
10-year range
0.6× to 188×
Peer median
1.4×

Traws Pharma's price to sales ratio is not a meaningful number today: revenue for one or more of the four quarters through 2026-06-30 is missing, so twelve months can't be added up.

It was last meaningful in Aug 2026, at 3.1×.

On the days it had one over the last ten years, its median was 25.8×, from 0.6× in Nov 2019 to 188× in Sep 2020.

Price to sales ratio over time

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far3.1×2.4×11.8×
20253.3×3.3×116×
2024180×21.8×180×
202369.7×57.5×130×
202260.2×60.2×183×
2021n/m a value too high to mean anything
2020188×1.1×188×
20191.5×0.6×30.4×
20189.0×8.2×41.5×
201718.1×1.1×21.2×
20161.0×0.7×10.1×
201512.1×11.8×130×
201431.3×22.1×39.9×

Against its peers

Companies in Healthcare nearest Traws Pharma's size, closest first, today.

CompanyPrice to sales ratio
TRAWTraws Pharman/m
OXBROXBRIDGE RE HOLDINGS2.8×
EDUCEducational Development0.4×
GTIMGood Times Restaurants0.1×
MDRRMedalist Diversified1.6×
BCGBinah Capital0.1×
VIPVulcan Infrastructure & Power0.4×
MXCMexco Energy3.0×
CKXCKX Lands31.0×
MSGMMotorsport Games1.5×
ATCHAtlasClear1.2×
Peer median1.4×

What the price to sales ratio tells you

Market value divided by revenue over the last twelve months. Useful for companies with little or no profit yet, since sales are harder to make negative than earnings.

Ignores margins entirely. A software company at 10× sales with 30% margins can be cheaper than a grocer at 1× sales with 2% margins.

More on Traws Pharma

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.